Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging

Journal of Nuclear Cardiology

Volumn 6, Issue 4, 1999, Pages 389-396

  Levine, Michael G ^a   Ahlberg, Alan W ^a   Mann, April ^a   White, Michael P ^a   McGill, Carol C ^a   De Leon, Carlos Mendes ^b   Piriz, Jose M ^a   Waters, David ^a,c   Heller, Gary V ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; SPECT imaging; Stress; Technetium 99m tetrofosmin

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXERCISE; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032875081     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90004-1     Document Type: Article

References (31)

1. Heller GV. Tracer selection with different stress modalities based on tracer kinetics. J Nucl Cardiol 1996;3:S15-S21.
2. Nielson AB, Morris KG, Murdock R, Bruno FP, Cobb FR, et al. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and non-ischemic myocardium during exercise. Circulation 1980;61:797-801.
3. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m hexakis-2methoxy-2-methylpropyl-isonitril. Circulation 1988;77:491-8.
4. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation 1990;81:628-36.
5. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, Berman DS. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
6. Wackers FJT, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-11.
7. 99mTc-isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989;15:280-6.
8. Kahn JK, McGhie I, Akers MS, Sills MN, Faber TL, Kulkami PV, et al. Quantitative rotational tomography with Tl-201 and Tc99m-2-methoxy-isobutyl-isonitrile: a direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79:1282-93.
9. Iskandrian AS, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989;64:270-5.
10. Sinusas AJ, Beller GA, Smith WH, Vinson EL, Brookeman V, Watson DD. Quantitative planar imaging with technetium-99m methoxy-isobutyl isonitrile: comparison of uptake patterns with thallium-201. J Nucl Med 1989;30:1456-63.
11. Tartagni F, Dondi M, Limonetti P, Franchi R, Maiello L, Monetti N, et al. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study. J Nucl Med 1991;32:369-76.
12. Sinusas AJ, Shi QX, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71.
13. Tamaki N, Takahashi N, Kawanoto M, Tatsuo T, Tadamura E, Yonekura Y, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
14. Flamen P, Bossuyt A, Franken P. Technetium-99mterofosmin in dipyridamole stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med 1995;36:2009-15.
15. Shanoudy H, Raggi P, Beller GA, Soliman A, Ammermann EG, Kastner RJ, et al. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary aretery disease. J Am Coll Cardiol 1998;31:331-7.
16. He Z, Iskandrian AS, Gupta NC, Verani MS. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial. J Nucl Med 1997;38:44-8.
17. Jain D, Wachers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-9.
18. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313-9.
19. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995;36:1961-7.
20. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300: 1350-8.
21. Shehata AR, Ahlberg AW, White MP, Russell A, Fleming IA, Levine MG, et al. Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging. Am J Cardiol 1998;82: 520-3.
22. Sinusas AJ, Shi QX, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71.
23. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813-20.
24. Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial technetium-99m tetrofosmin uptake during adenosine-induced vasodilation with either a critical or mild coronary stenosis: comparison to thallium-201 and regional myocardial blood flow. Circulation 1997;96:2332-8.
25. Meleca MJ, McGovern AJ, Gerson MC, Millard RW, Gabel M, Biniakiewicz, et al. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia. J Nucl Med 1997;38:1847-56.
26. Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med 1994;35:535-41.
27. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, et al. Comparison of exercise, dipyridamole, and adenosine by use of technetium-99m sestamibi tomographic imaging. J Nucl Cardiol 1994;1:57-64.
28. Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, et al. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 1998;5:265-74.
29. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, et al. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994;73:164-9.
30. Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P, et al. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol 1996;3:194-203.
31. Taillefer R, Amyot R, Turpin S, Lambert R, Pilon C, Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol 1996;3:204-11.